Epstein S L, Stack A, Misplon J A, Lo C Y, Mostowski H, Bennink J, Subbarao K
Molecular Immunology Laboratory, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, HFM-521, Building 29B, Room 2G15, 29 Lincoln Drive, Bethesda, MD 20892-4555, USA.
Int Immunol. 2000 Jan;12(1):91-101. doi: 10.1093/intimm/12.1.91.
DNA vaccination offers the advantages of viral gene expression within host cells without the risks of infectious virus. Like viral vaccines, DNA vaccines encoding internal influenza virus proteins can induce immunity to conserved epitopes and so may defend the host against a broad range of viral variants. CD8(+) cytotoxic T lymphocytes (CTL) have been described as essential effectors in protection by influenza nucleoprotein (NP), although a lesser role of CD4(+) cells has been reported. We immunized mice with plasmids encoding influenza virus NP and matrix (M). NP + M DNA allowed B6 mice to survive otherwise lethal challenge infection, but did not protect B6-beta(2)m(-/-) mice defective in CD8(+) CTL. However, this does not prove CTL are required, because beta(2)m(-/-) mice have multiple immune abnormalities. We used acute T cell depletion in vivo to identify effectors critical for defense against challenge infection. Since lung lymphocytes are relevant to virus clearance, surface phenotypes and cytolytic activity of lung lymphocytes were analyzed in depleted animals, along with lethal challenge studies. Depletion of either CD4(+) or CD8(+) T cells in NP + M DNA-immunized BALB/c mice during the challenge period did not significantly decrease survival, while simultaneous depletion of CD4(+) and CD8(+) cells or depletion of all CD90(+) cells completely abrogated survival. We conclude that T cell immunity induced by NP + M DNA vaccination is responsible for immune defense, but CD8(+) T cells are not essential in the active response to this vaccination. Either CD4(+) or CD8(+) T cells can promote survival and recovery in the absence of the other subset.
DNA疫苗接种具有在宿主细胞内实现病毒基因表达的优势,同时不存在感染性病毒的风险。与病毒疫苗一样,编码流感病毒内部蛋白的DNA疫苗可诱导针对保守表位的免疫反应,因此可能保护宿主抵御多种病毒变体。CD8(+)细胞毒性T淋巴细胞(CTL)被认为是流感核蛋白(NP)发挥保护作用的关键效应细胞,不过也有报道称CD4(+)细胞的作用较小。我们用编码流感病毒NP和基质蛋白(M)的质粒免疫小鼠。NP + M DNA可使B6小鼠在原本致命的攻击感染中存活,但不能保护CD8(+) CTL有缺陷的B6-β2m(-/-)小鼠。然而,这并不能证明CTL是必需的,因为β2m(-/-)小鼠存在多种免疫异常。我们在体内进行急性T细胞耗竭实验,以确定对抵御攻击感染至关重要的效应细胞。由于肺淋巴细胞与病毒清除相关,我们在耗竭的动物中分析了肺淋巴细胞的表面表型和细胞溶解活性,并进行了致命攻击研究。在攻击期,对NP + M DNA免疫的BALB/c小鼠耗竭CD4(+)或CD8(+) T细胞,并不会显著降低存活率,而同时耗竭CD4(+)和CD8(+)细胞或耗竭所有CD90(+)细胞则会完全消除存活率。我们得出结论,NP + M DNA疫苗接种诱导的T细胞免疫负责免疫防御,但CD8(+) T细胞在对这种疫苗接种的主动反应中并非必需。在没有另一亚群的情况下,CD4(+)或CD8(+) T细胞均可促进存活和恢复。